Characteristics of the included studies
We initially identified 468 studies, of which 10 (n = 833 participants) were ultimately included in our analysis (Fig. 1). A total of 174 duplicate articles were removed from the initial 468 studies. By reading the abstract and title, we removed an additional 272 case reports, protocols, pilot studies, reviews, and articles in which the disease under discussion was not an ED or in which the treatment was not IPT. After reading the full text of the qualified articles, we discarded a further 12 because their treatment method was not IPT or the disease under study was not an ED.
The 10 trials that we reviewed in full were all RCTs that directly compared CBT with IPT in the same experiment (Table 1). The mean trial duration was 18 weeks. The mean age of the participants ranged from 24.2 to 50.3 years. Sample types included BED [1, 34, 38, 40], AN [7, 31], and BN [9, 15, 13]. Eight trials included a follow-up and compared IPT with CBT [1, 13, 15, 19, 31, 34, 38, 40]. The follow-up time spans more than 12 months. Two trials compared IPT with CBT and had no specific control management [7, 31]. One trial compared IPT with CBT and behavioral weight loss treatment [40].
Table 1
Studies included in the Meta-analysis and their Characteristics
Study
|
Sample type
|
Study design
|
N
(each group)
|
Age (years,mean)
|
Design
|
Other intervention aspects
|
Outcome measure
|
Agras, 1995
|
Binge eating disorder (BED)
|
RCT
|
31,11
|
47.6
|
24 weeks of IPT
Vs. CBT
|
Assessments occurred at pre-treatment, 12 and 24 weeks follow-up
|
EDE
BES
IIP
SCL-90
BDI
|
Carter, 2010
|
Anorexia Nervosa
|
RCT
|
14,17༌12
|
NA
|
at least 20 weeks of IPT vs.
CBT vs NSCM
|
Assessments occurred at pre-treatment and post-treatment
|
global anorexia nervosa measure
|
Chui, 2007
|
Bulimia
Nervosa
|
RCT
|
59,65
|
28.61
|
at least 20 weeks of IPT vs.
CBT
|
Assessments occurred at pre-treatment, post-treatment and 12 weeks follow-up
|
BMI
EDE
SCID
SCL-90
IIP
RSS
|
Fairburn, 1993
|
Bulimia
Nervosa
|
RCT
|
25,25
|
24.2
|
at least 18 weeks of IPT vs.
CBT
|
Assessments occurred at
pre-treatment, post-treatment,4,8, and 12 months follow-up
|
EDE
EAT
|
Fairbunr, 2015
|
Bulimia
Nervosa
|
RCT
|
65,65
|
26.8,
24.9
|
at least 20 weeks of IPT vs.
CBT
|
Assessments occurred at
pre-treatment, post-treatment,20,40 and 60weeks follow-up
|
EDE
|
Hilbert, 2012
|
Binge eating disorder (BED)
|
RCT
|
45,45
|
44.02,
45.73
|
at least 20 weeks of IPT vs.
CBT
|
Assessments occurred at pre-treatment, post-treatment, 1-year follow-up and long-term follow-up
|
EDE
EDE-Q
BSI
BMI
|
Mcintosh, 2005
|
Anorexia Nervosa
|
RCT
|
21,19,
16
|
NA
|
at least 20 weeks of IPT vs.
CBT vs NSCM
|
Assessments occurred at pre-treatment. post-treatment
|
GAF
DSM-IV
EDE
|
Tasca, 2012
|
Binge eating disorder (BED)
|
RCT
|
48,47
|
32.7
|
16 weeks of GPIP
Vs. GCBT
|
Assessments occurred at
Pre-treatment, Post-treatment and six month follow-up
|
IIP
EDE
TRIPED
|
Wlifley, 2002
|
Binge eating disorder (BED
|
RCT
|
81,81
|
25.7,
24.7
|
20 weeks of IPT
Vs. CBT
|
Assessments occurred at
Pre-treatment, Post-treatment ,4,8 and 12 month follow-up
|
EDE
IIP
BMI
DSM-Ⅲ-R
|
Wilson, 2010
|
Binge eating disorder (BED)
|
RCT
|
75,64,
66
|
48.7,
46.2,
50.3
|
24 weeks of IPT
Vs. BWL Vs. CBTgsh
|
Assessments occurred at
Pre-treatment, Post-treatment ,1 and 2 year follow-up
|
EDE
DSM-IV
|
Abbreviation: IPT༚interpersonal phychotherapy, CBT: cognitive behavioral therapy, BES: Binge Eating Scale, BDI: Beck Depression Inventory, IIP: Inventory of Interpersonal Problems, SCL-90: Symptom Check List — 90, BMI: Body Mass Index, RSS: Rosenberg Self-esteem Scale, EAT: Eating Attitude Test, EDE-Q: Eating Disorder Examination Questionnaire, BSI: Brief Symptom Inventory, GAF: Global Assessment of Functioning |
Quality assessment and publication bias
The Cochrane Risk of Bias assessment is shown in Fig. 2A, which shows that the common risk factor for bias was random sequence generation. Five of the ten studies did not use random sequences entirely, which could have resulted in the participants not being randomized. Fig. 2B shows the risk of bias: seven of the ten studies did not clearly describe the allocation method. However, all of the trials used blinding and had a low risk of bias.
Primary outcome analysis
Fig. 3A shows the effects of IPT compared to CBT in the treatment of EDs. The meta-analysis revealed similar effects compared to CBT in reducing EDE scores. Pooling the data of all these studies showed that IPT led to a mean reduction in scale score that was close to or slightly better than CBT (10 studies, n = 833, SMD = 0.08, 95% CI: -0.07 to 0.22, p = 0.29), and we detected no publication bias (p = 0.29, Fig. 3A). The heterogeneity of the literature data was low (p = 0.37, I² = 7%). The funnel plot, as shown in Fig. 3B, identified no outlier studies. Egger’s test showed no published offset (p = 0.932).
Follow-up effect analysis of IPT versus CBT
To analyze the follow-up effects (Fig. 4), we conducted statistical analysis on the basis of dividing the follow-up periods into three time frames (less than 6 months, 6–12 months, and more than 12 months). The three time frames of pre-test and follow-up comparison all showed follow-up effects in fewer than six months (CBT: SMD = 1.83, 95% CI: 0.28–3.39; IPT: SMD = 1.61, 95% CI: 0.38–2.85), 6–12 months (CBT: SMD = 1.65, 95% CI: 0.82–2.48; IPT: SMD = 1.48, 95% CI: 0.79–2.18) and more than 12 months (CBT: SMD = 1.33, 95% CI: 1.00–1.66; IPT: SMD = 1.29, 95% CI: 1.06–1.51). However, no differences in terms of follow-up effects between IPT and CBT were identified.
Secondary outcome analysis
As a secondary outcome, we analyzed the IIP to provide additional evidence regarding the effects of IPT and CBT. Five studies (n = 574) were incorporated into the analysis. Fig. 5 illustrates that this analysis showed IPT to be slightly superior than CBT (SMD = 0.32, 95% CI: 0.07–0.56, p = 0.01, I² = 38).
Subgroup analysis
To perform subgroup analysis, first, we compared the therapeutic effects of IPT and CBT between two patient types: patients with AN and patients with BN (Fig. 6A). The results showed that the two treatments were equivalent in terms of their therapeutic effect (AN: SMD = 0.16, 95% CI: -0.31–0.62; BN: SMD = 0.07, 95% CI: -0.10–0.24). An additional subgroup analysis examined whether age made any difference to treatment effect (Fig. 6B). For people older than 40, the two treatments had the same therapeutic effect (SMD = 0.17, 95 CI%: -0.07–0.42, p = 0.17), while for people younger than 40, IPT had a greater effect size (SMD = 0.43, 95% CI: 0.25–0.61, p < 0.001).
In the BMI subgroup analysis (Fig. 6C), we found that people with a BMI of less than 30 had a larger effect size when comparing IPT to CBT (SMD = 0.27, 95% CI: 0.06–0.48, p = 0.01) as opposed to people with a BMI higher than 30 (SMD = -0.34, 95% CI: -0.83–0.15, p = 0.17). Moreover, there were significant differences between the subgroups (p = 0.03).
Meta-regression analysis of treatment sessions
The meta-regression analysis showed that CBT had a trend of dose-response relationship (β = 0.017, p = 0.067, Fig. 7A), suggesting that the more sessions a patient underwent, the better the effect. IPT, on the other hand, showed no dose-response relationship (β = 0.003, p = 0.495, Fig. 7B).